<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<pubmed-document>
<record>
<header>
<identifier>27498113</identifier>
<setSpec>1699-7980</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:author>Hernández, V</dc:author>
<dc:author>Guijarro, A</dc:author>
<dc:author>Llorente, C</dc:author>
<dc:description xml:lang="en">BACKGROUND Lymphadenectomy is part of standard treatment for muscle invasive bladder cancer. The objective of this review is to provide an up-to-date review on the available scientific evidence in this field. ACQUISITION OF EVIDENCE We conducted a literature review in PubMed of relevant articles up to the present (2016). We found a systematic review published in 2014 that included the comparative studies published up to that year, and we updated the review with new relevant publications since that date. SYNTHESIS OF THE EVIDENCE The number of lymph nodes is not the best indicator for determining the quality of the lymphadenectomy given that the number can vary depending on numerous factors that depend not only on the surgeon but also on the patient and on the pathologist. The definition of standard anatomical territories and a meticulous extraction of the lymph nodes in these territories are more reproducible than the numbers of nodes removed. The optimal extension of lymphadenectomy is a topic of debate. The evidence published to date indicates that any extension of lymphadenectomy is better than not performing it, although it appears that limited lymphadenectomy is insufficient for the oncological control of the disease and that superextended lymphadenectomy provides no oncological benefit versus extended lymphadenectomy. CONCLUSIONS Despite a certain amount of controversy in terms of the optimal extension of lymphadenectomy, performing lymphadenectomy in all cases appears to be recommendable according to the available evidence. Extended lymphadenectomy provides greater oncological benefit than more limited dissections, while more extensive lymphadenectomies are not recommended.</dc:description>
<dc:type>Journal Article</dc:type>
<dc:language>es</dc:language>
<dc:subject>Oncological value</dc:subject>
<dc:subject>Lymphadenectomy</dc:subject>
<dc:subject>Cáncer vesical con infiltración de la muscular</dc:subject>
<dc:subject>Linfadenectomía</dc:subject>
<dc:subject>Valor oncológico</dc:subject>
<dc:subject>Territorios anatómicos ganglionares</dc:subject>
<dc:subject>Muscle invasive bladder cancer</dc:subject>
<dc:subject>Lymph node anatomical territory</dc:subject>
<dc:date>2017 Jun </dc:date>
<dc:title xml:lang="es">Límites anatómicos y beneficio oncológico de la linfadenectomía en el cáncer urotelial de vejiga con infiltración muscular.</dc:title>
<dc:title xml:lang="en">The anatomical limits and oncological benefit of lymphadenectomy in muscle invasive bladder cancer.</dc:title>
<dc:publisher>Actas urologicas espanolas</dc:publisher>
</metadata>
</record>
</pubmed-document>
